Search Thermo Fisher Scientific
用于癌症研究的强大靶向新一代测序技术
癌症是复杂的一致性基因组疾病,同时影响体生殖系细胞和体细胞。多数癌症是由于引起癌症相关基因功能失调的多种基因改变集聚造成的。新一代测序(NGS)让您能够通过单次测试,更快速地获得更多结果。
通过 Oncomine 检测和 Ion Torrent 测序技术,您可采用超低起始量的 FFPE DNA 和 RNA 同时测序数百个癌症基因 。作为临床 NGS 专家,我们可提供从样本至注释结果的综合工作流程,帮助您完成每一个操作步骤,让您快速顺利上手。
传统的基因检测方法包括依次进行的单基因测试,以便确定是否存在目标变异。鉴于样本自身的规模,逐个反复检测缩小了正确答案的范围,连续检测往往不能得到确切的结果。此外,连续检测还颇费人力和资金,需要工作许多周才能找到正确答案。
通过新一代测序(NGS)技术,您可以通过单次实验的单个样本,分析样本之中的数百个目标变异。您可通过 单次运行检测热点基因、SNV、indels、CNV和基因融合。通过 Ion AmpliSeq™ 技术,您仅需要几片 FFPE 切片或 10 ng 样本 DNA 和 RNA 即可观测到结果。
Accelerate your cancer research with a more complete approach to NGS. Oncomine assays are multibiomarker targeted NGS assays specifically designed to give you the tools you need for oncology clinical research, including panels, reagents, and informatics software.
Each assay is manufactured with enhanced quality control and is tested on clinical research samples to help ensure results are accurate and meaningful.
The primer panels are carefully designed to deliver relevant information, so you can analyze multiple gene aberrations across a variety of sample types.
The workflow is integrated and streamlined to help you generate answers in less than two days, starting from minimum material, to help reduce your risk of sample consumption prior to obtaining a meaningful result.
Whether your interest is just a few or many targets, Ion AmpliSeq technology is flexible to suite your needs—use it with any genome across many applications from inherited disease research to microbial analysis to cancer research applications.
Whether you choose ready-to-use or custom panel designs, Ion AmpliSeq panels leverage the primer design technology that has enabled thousands of real-world designs resulting in more than 600 publications in which Ion AmpliSeq technology was used.
采用 Oncomine 检测搭配 Ion PGM™ 系统和 Ion Reporter™ 软件,可以简化您的工作流程,从而更快速获取结果。这一经过优化的简单系统让您可以在一天之内从样本获得变异结果。基于芯片的 Ion PGM™ 系统采用灵活设计理念,让您可以在不牺牲经济性的前提下,运行一至数百个样本。即,您可以自行安排时间运行自己的样本,不必采用更大、灵活性更差的 NGS 系统浪费更多时间运行完整批次的样本。
仅供研究使用。不可用于诊断操作。